gastrointestinal Clinical Trials in Beijing, Beijing Municipality
15 recruitingBeijing, Beijing Municipality, China
Showing 1–15 of 15 trials
Recruiting
Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Pancreatic Neuroendocrine TumorVon Hippel-Lindau DiseasePheochromocytoma/Paraganglioma+2 more
Merck Sharp & Dohme LLC322 enrolled84 locationsNCT04924075
Recruiting
Phase 2
Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment
GIST - Gastrointestinal Stromal TumorKIT Gene Mutation
Jian Li100 enrolled1 locationNCT07559864
Recruiting
Not Applicable
MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT
Gastrointestinal Stromal Tumor of StomachSubmucosal Tumor of Stomach
Peking University People's Hospital96 enrolled1 locationNCT06748690
Recruiting
Not Applicable
OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding
Upper Gastrointestinal Bleeding
Chinese University of Hong Kong236 enrolled5 locationsNCT04902248
Recruiting
Phase 1
A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
Solid TumorsGastrointestinal Tumors
Sichuan Baili Pharmaceutical Co., Ltd.33 enrolled1 locationNCT07279428
Recruiting
Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
Gastrointestinal Bleeding
Xingshun Qi3,000 enrolled23 locationsNCT04662918
Recruiting
Phase 1
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
Gastrointestinal Tumor
Sichuan Baili Pharmaceutical Co., Ltd.96 enrolled6 locationsNCT05262491
Recruiting
Phase 1
Study of VEGF-A Targeting NIR-II Fluorescence Endoscopy in the Gastrointestinal Tract
DysplasiaGastrointestinal CarcinomaGastrointestinal Polyp
Institute of Automation, Chinese Academy of Sciences30 enrolled1 locationNCT06430372
Recruiting
Phase 1Phase 2
OH2 Oncolytic Viral Therapy in Solid Tumors
Solid TumorGastrointestinal Cancer
Binhui Biopharmaceutical Co., Ltd.300 enrolled1 locationNCT03866525
Recruiting
Phase 2
A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
Gastrointestinal Neuroendocrine Pancreatic Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.90 enrolled1 locationNCT06505395
Recruiting
Phase 1Phase 2
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
NeoplasmsNeoplasm MetastasisMetastatic Gastrointestinal Carcinoid Tumor
Shanghai EpimAb Biotherapeutics Co., Ltd.152 enrolled14 locationsNCT05176665
Recruiting
Not Applicable
PD-L1 Targeting Molecular Imaging of Solid Tumors
Gastrointestinal Tumors
Peking University Cancer Hospital & Institute20 enrolled1 locationNCT04629326
Recruiting
Phase 2
First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma
Gastrointestinal Neuroendocrine Carcinoma
Peking Union Medical College Hospital22 enrolled1 locationNCT06070740
Recruiting
Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence
Gastrointestinal Stromal Tumors
Peking University People's Hospital40 enrolled1 locationNCT05867901
Recruiting
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Minimal Residual DiseaseGastrointestinal Stromal Tumors
Peking University People's Hospital45 enrolled1 locationNCT05408897